Navigation Links
Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis
Date:5/22/2013

velopment of new treatments and accelerating clinical trials."

Lupus nephritis is one of the most common and most serious complications of lupus potentially causing kidney failure if uncontrolled.  An estimated one-third to one-half of lupus patients develops lupus nephritis within the first six months to three years of their lupus diagnosis. There is no cure for lupus nephritis, and current treatments rely on anti-inflammatory and immunosuppressive drugs that carry the risk of serious side effects.  

About Lupus
Lupus is a chronic, complex and prevalent autoimmune disease that affects more than 1.5-million Americans. In lupus, the immune system, which is designed to protect against infection, creates antibodies that attack the body's own tissues and organs.

About the Lupus Research Institute
The Lupus Research Institute (LRI), the world's leading private supporter of innovative research, pioneers discovery and champions scientific creativity to find solutions to lupus. The LRI's advocacy arm is its National Patient Coalition, a powerful network of state and local lupus organizations in large urban centers of the country that unite to prevent, treat and cure lupus by advocating for lupus on Capitol Hill.


'/>"/>
SOURCE Lupus Research Institute
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. New Published Guidelines to Help Physicians Diagnose and Treat Lupus Kidney Disease
2. Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for Discoid Lupus
3. Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE)
4. Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit
5. Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
6. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
7. Two Of The Nations Top Specialists In Lupus, Drs. Swamy Venuturupalli & Daniel Wallace, Join In Expanding Research On Auto-Immune Diseases
8. For the Treatment of Lupus, the Emerging Therapies Epratuzumab and Lupuzor Have the Potential to Offer Improvements Over IV Belimumab in Reducing Disease Activity
9. Lupus Foundation of Florida Applauds Support for Biosimilars Legislation
10. Army Researcher Develops Potential Vaccine Carrier That May Give Stockpiling Efforts A Shot In The Arm
11. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Germany und LONDON ... , Ziel der Zusammenarbeit sind ... genomischer Daten aus Plasmaproben zur Steuerung von Therapien ... werden kann  Neuer Bluttest basiert auf ... und soll auf Rotor-Gene Q, einer Automationsplattform der ...
(Date:7/28/2014)... 2014 OmPrompt today announces ... help it meet the global demand for customer ... logistics. Albion joins Shackleton Ventures.      ... the past 18 months OmPrompt has underpinned accelerated ... team and its operations. The new funding will ...
(Date:7/25/2014)... N.C. , July 25, 2014  In today,s ... is costly and challenging - as is managing a ... Is it possible - or even preferable ... If so, where can you combine resources and activities, ... These are just a few of ...
Breaking Medicine Technology:QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 2QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 3QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 4QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 5QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 6QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 7OmPrompt Funded for Customer Automation Management Market Expansion 2Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2
... April 11, 2011 iCyt Mission Technology, Inc. (iCyt), ... announced the introduction of its new line of 405nm-excited ... Violet™ 421 products are part of the first commercial ... "This exciting new class of fluorescent probes will ...
... 11, 2011 Leading-edge Clinical Pharmacology and Cardiac ... announces the addition of Aziz Karim, BPharm, PhD, ... and advisor to Spaulding,s Clinical Pharmacology/Pharmacokinetic department.   ... the principles of Clinical Pharmacology and rational drug ...
Cached Medicine Technology:iCyt Unveils Exciting New Flow Cytometry Reagents Utilizing Innovative Fluorochrome Technology 2Spaulding Clinical Welcomes Dr. Aziz Karim, Clinical Pharmacokinetic Consultant 2
(Date:7/28/2014)... 2014 Qualis Health, one of ... organizations, has published a complimentary, online toolkit that ... patients and families in infection control. Tested ... the toolkit provides a step-by-step roadmap for implementing ... their families early in a hospital stay. , ...
(Date:7/28/2014)... North America Carotenoids & Antioxidants Market report defines and segments ... and forecast of revenue. This market is estimated to grow ... 2018, at a CAGR of 7.1% from 2013 to 2018. ... & Antioxidants Market report to get an idea of the ... segmentation in the market, and is supported by various tables ...
(Date:7/28/2014)... News) -- People with higher levels of brown fat ... new study suggests. Unlike white fat, which lowers ... insulin sensitivity, blood sugar control and fat-burning metabolism. ... Labros Sidossis, a professor of internal medicine in the ... Medical Branch at Galveston, said in a university ...
(Date:7/28/2014)... decision tree analysis, incorporating Donabedian,s model, is a ... available quality standards, guidelines, recommendations and indicators ... standards for radiation therapy, according to a study ... Practical Radiation Oncology (PRO), the official clinical ... Oncology (ASTRO). , Guidelines, recommendations and indicators may ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 A young ... to the all-too-often stories in the media today about ... occur in a matter of minutes in a hot ... to the Office of Emergency Medical Services at NHTSA. ... app for smartphones. Realizing that it’s all too easy ...
Breaking Medicine News(10 mins):Health News:Patient Engagement in Hospital Infection Control: Online Toolkit Provides a New Solution 2Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Healthy 'Brown Fat' May Cut Odds for Obesity, Diabetes 2Health News:Two-step decision tree analysis helps inform updates of RT best practices, quality standards 2Health News:Two-step decision tree analysis helps inform updates of RT best practices, quality standards 3Health News:'Precious Cargo' App Released to Help Save Babies from the Dangers of Being Accidentally Left Behind in Hot Cars 2
... find themselves in a sticky situation having failed to meet ... lapses in// sticking to rules pertaining to blood safety, ... the total penalty toll against the American Red Cross ... the organization had been fined close to $5.7 million, ...
... amyotrophic lateral sclerosis (ALS), the most common form of ... successful compiling of genetic information on more than 1,000 ... by The Packard Center for ALS Research at Johns ... (NINDS) and the ALS Association, present their initial findings ...
... a lot of other countries, Japan is keen to ... universities, which are currently restricted only to those// who ... of the undergraduate courses like biotechnology and neurosciences to ... prime minister. He is also a professor at the ...
... to the needs of about 1,000 people annually. ... Award for Excellence in Weight// Management 2006 to ... standards that were maintained by this clinic. Glowing ... that offer simple,yet comprehensive solutions to treat obesity. ...
... South Africans are coming forward to seek counseling and ... HIV figures, the Department of Health has reported.// ... have utilized the screening services since 2000, thanks to ... their status. In 2005/06, nearly 1.7-million people underwent the ...
... Welfare stressed the urgency to focus on health and education. ... million people are suffering with HIV/AIDS, and also putting a ... be noted that more than 50 percent of the AIDS ... to be women. Ramadoss expressed how the campaign had slightly ...
Cached Medicine News:Health News:American Red Cross Face Fines After Blood Safety Lapses 2Health News:First International Gene Screen for Typical ALS Is on Track 2
Double Ended Occluders...
49 pinholes, black...
Double Ended Occluders...
Designed to provide occlusion while permitting observation of the eye. Helpful to determine if only one eye is deviating. Approximately 9 inches long....
Medicine Products: